ProShare Advisors’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $456K | Sell |
32,582
-879
| -3% | -$12.3K | ﹤0.01% | 1174 |
|
2025
Q1 | $455K | Sell |
33,461
-8,364
| -20% | -$114K | ﹤0.01% | 1145 |
|
2024
Q4 | $852K | Buy |
41,825
+9,877
| +31% | +$201K | ﹤0.01% | 983 |
|
2024
Q3 | $931K | Buy |
31,948
+7,150
| +29% | +$208K | ﹤0.01% | 838 |
|
2024
Q2 | $576K | Sell |
24,798
-6,407
| -21% | -$149K | ﹤0.01% | 906 |
|
2024
Q1 | $640K | Buy |
31,205
+2,820
| +10% | +$57.9K | ﹤0.01% | 954 |
|
2023
Q4 | $609K | Buy |
28,385
+4,053
| +17% | +$87K | ﹤0.01% | 932 |
|
2023
Q3 | $502K | Buy |
24,332
+109
| +0.4% | +$2.25K | ﹤0.01% | 912 |
|
2023
Q2 | $715K | Buy |
24,223
+1,937
| +9% | +$57.2K | ﹤0.01% | 808 |
|
2023
Q1 | $513K | Sell |
22,286
-4,622
| -17% | -$106K | ﹤0.01% | 901 |
|
2022
Q4 | $748K | Buy |
26,908
+4,119
| +18% | +$115K | ﹤0.01% | 806 |
|
2022
Q3 | $700K | Buy |
22,789
+615
| +3% | +$18.9K | ﹤0.01% | 796 |
|
2022
Q2 | $653K | Sell |
22,174
-9,707
| -30% | -$286K | ﹤0.01% | 863 |
|
2022
Q1 | $1.03M | Sell |
31,881
-7,521
| -19% | -$242K | ﹤0.01% | 913 |
|
2021
Q4 | $1.76M | Sell |
39,402
-435
| -1% | -$19.4K | ﹤0.01% | 797 |
|
2021
Q3 | $2.01M | Sell |
39,837
-5,525
| -12% | -$279K | 0.01% | 712 |
|
2021
Q2 | $3.56M | Buy |
45,362
+11,785
| +35% | +$924K | 0.01% | 571 |
|
2021
Q1 | $1.92M | Buy |
33,577
+1,139
| +4% | +$65K | 0.01% | 712 |
|
2020
Q4 | $2.72M | Buy |
32,438
+7,651
| +31% | +$641K | 0.01% | 566 |
|
2020
Q3 | $888K | Sell |
24,787
-637
| -3% | -$22.8K | ﹤0.01% | 754 |
|
2020
Q2 | $615K | Buy |
25,424
+9,145
| +56% | +$221K | ﹤0.01% | 862 |
|
2020
Q1 | $285K | Sell |
16,279
-10,987
| -40% | -$192K | ﹤0.01% | 891 |
|
2019
Q4 | $475K | Sell |
27,266
-4,124
| -13% | -$71.8K | ﹤0.01% | 1086 |
|
2019
Q3 | $481K | Sell |
31,390
-1,299
| -4% | -$19.9K | ﹤0.01% | 999 |
|
2019
Q2 | $679K | Sell |
32,689
-4,522
| -12% | -$93.9K | ﹤0.01% | 901 |
|
2019
Q1 | $864K | Buy |
37,211
+226
| +0.6% | +$5.25K | 0.01% | 830 |
|
2018
Q4 | $764K | Buy |
+36,985
| New | +$764K | 0.01% | 789 |
|